Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

171 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes.
Sharif NA, Xu SX, Crider JY, McLaughlin M, Davis TL. Sharif NA, et al. J Ocul Pharmacol Ther. 2001 Aug;17(4):305-17. doi: 10.1089/108076801753162726. J Ocul Pharmacol Ther. 2001. PMID: 11572462
In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma.
Chen HH, Namil A, Severns B, Ward J, Kelly C, Drace C, McLaughlin MA, Yacoub S, Li B, Patil R, Sharif N, Hellberg MR, Rusinko A, Pang IH, Combrink KD. Chen HH, et al. Bioorg Med Chem Lett. 2014 Apr 15;24(8):1875-9. doi: 10.1016/j.bmcl.2014.03.017. Epub 2014 Mar 19. Bioorg Med Chem Lett. 2014. PMID: 24684843
[(3)H]-serotonin release from bovine iris-ciliary body: pharmacology of prejunctional serotonin (5-HT(7)) autoreceptors.
Harris LC, Awe SO, Opere CA, Leday AM, Ohia SE, Sharif NA. Harris LC, et al. Among authors: sharif na. Exp Eye Res. 2001 Jul;73(1):59-67. doi: 10.1006/exer.2001.1012. Exp Eye Res. 2001. PMID: 11428863
Pharmacology of Serotonin Receptors Causing Contraction of Isolated Bovine Posterior Ciliary Arteries: Role in Ocular Blood Flow.
Njie-Mbye YF, Robinson J, Mitchell-Bush L, Mckoy M, Opere CA, Ohia SE, Sharif N. Njie-Mbye YF, et al. J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):134-140. doi: 10.1089/jop.2017.0124. Epub 2018 Jan 25. J Ocul Pharmacol Ther. 2018. PMID: 29369737
Introduction to Volume 1 of JOPT Special Issue.
Sharif N, Ohia S, Yorio T. Sharif N, et al. J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):1-2. doi: 10.1089/jop.2017.29037.int. Epub 2018 Jan 24. J Ocul Pharmacol Ther. 2018. PMID: 29364758 No abstract available.
Introduction to Volume 2 of JOPT Special Issue.
Sharif N, Ohia S, Yorio T. Sharif N, et al. J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):3. doi: 10.1089/jop.2017.29038.int. Epub 2018 Jan 24. J Ocul Pharmacol Ther. 2018. PMID: 29364769 No abstract available.
Serotonin-2B/2C Receptors Mediate Bovine Ciliary Muscle Contraction: Role in Intraocular Pressure Regulation.
Ohia SE, Njie-Mbye YF, Robinson J, Mitchell L, Mckoy M, Opere CA, Sharif NA. Ohia SE, et al. Among authors: sharif na. J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):70-75. doi: 10.1089/jop.2017.0123. Epub 2018 Jan 24. J Ocul Pharmacol Ther. 2018. PMID: 29364761
Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
Sharif NA, Williams GW, Crider JY, Xu SX, Davis TL. Sharif NA, et al. J Ocul Pharmacol Ther. 2004 Dec;20(6):489-508. doi: 10.1089/jop.2004.20.489. J Ocul Pharmacol Ther. 2004. PMID: 15684809
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.
Hellberg MR, McLaughlin MA, Sharif NA, DeSantis L, Dean TR, Kyba EP, Bishop JE, Klimko PG, Zinke PW, Selliah RD, Barnes G, DeFaller J, Kothe A, Landry T, Sullivan EK, Andrew R, Davis AA, Silver L, Bergamini MV, Robertson S, Weiner AL, Sallee VL. Hellberg MR, et al. Among authors: sharif na. Surv Ophthalmol. 2002 Aug;47 Suppl 1:S13-33. doi: 10.1016/s0039-6257(02)00293-x. Surv Ophthalmol. 2002. PMID: 12204698
Human ciliary muscle cell responses to FP-class prostaglandin analogs: phosphoinositide hydrolysis, intracellular Ca2+ mobilization and MAP kinase activation.
Sharif NA, Crider JY, Husain S, Kaddour-Djebbar I, Ansari HR, Abdel-Latif AA. Sharif NA, et al. J Ocul Pharmacol Ther. 2003 Oct;19(5):437-55. doi: 10.1089/108076803322473006. J Ocul Pharmacol Ther. 2003. PMID: 14583136
171 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback